Table 1.
Full Sample (n=20,916)
|
Whites (n=17,574)
|
Blacks (n=3,342)
|
|||||
---|---|---|---|---|---|---|---|
Continuous Variables | M | SD | M | SD | M | SD | t1 |
Age | 77.1 | 7.0 | 77.3 | 7.0 | 75.9 | 7.0 | 10.94*** |
MHI (in thousands) | 49.7 | 24.1 | 52.4 | 24.2 | 35.5 | 17.3 | 47.55*** |
Categorical Variables | % | N | % | N | % | N | x2 |
| |||||||
Sex | |||||||
Male | 52 | 10,988 | 54 | 9,432 | 47 | 1,556 | 56.95*** |
Female | 48 | 9,928 | 46 | 8,142 | 53 | 1,786 | |
Medicaid Beneficiary | |||||||
Yes | 15 | 3,089 | 11 | 1,966 | 34 | 1,123 | 1120.89*** |
No | 85 | 17,287 | 89 | 15,608 | 66 | 2,219 | |
Urban/Rural Status | |||||||
Metro | 83 | 17,378 | 82 | 14,484 | 87 | 2,894 | 52.74*** |
Urban | 15 | 3,087 | 15 | 2,667 | 13 | 420 | |
Rural | 2 | 444 | 2 | 418 | 1 | 26 | |
Performance Status | |||||||
Normal | 80 | 16,643 | 81 | 14,189 | 73 | 2,454 | 92.29*** |
Poor | 20 | 4,273 | 19 | 2,454 | 27 | 888 | |
CCI | |||||||
0 | 51 | 10,619 | 53 | 9,261 | 41 | 1,358 | 223.98*** |
1 | 23 | 4,806 | 23 | 4,013 | 24 | 793 | |
2 | 12 | 2,595 | 12 | 2,073 | 16 | 522 | |
3+ | 14 | 2,896 | 13 | 2,227 | 20 | 669 | |
SCT Utilization2 | |||||||
Yes | 7 | 782 | 8 | 700 | 4 | 82 | 34.37*** |
No | 93 | 10,487 | 92 | 8,506 | 96 | 1,981 | |
BTZ Utilization3 | |||||||
Yes | 35 | 5,672 | 36 | 4,882 | 30 | 790 | 39.10*** |
No | 65 | 10,365 | 64 | 8,525 | 70 | 1,840 |
Note: BTZ= Bortezomib; CCI= Charlson Comorbidity Index; MHI= Median Household Income; SCT = Stem Cell Transplant;
= p < 0.01;
= p < 0.001;
= p < 0.0001.
T and P values for comparison between whites and blacks
Limited to only those ≤77 years old at MM diagnosis (n= 11,269)
Limited to only those diagnosed 2003–2011 (n= 16,037)